New York State Common Retirement Fund
ELEV

New York State Common Retirement Fund’s Elevation Oncology ELEV Stock Holding History

New York State Common Retirement Fund’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,200
Closed -$1.35K – 3239
2025
Q1 		$1.35K Hold
5,200
– – ﹤0.01% 3164
2024
Q4 		$2.93K Hold
5,200
– – ﹤0.01% 3155
2024
Q3 		$3.12K Sell
5,200
-34,700
-87% -$51.5K ﹤0.01% 3157
2024
Q2 		$108K Buy
+39,900
New +$150K ﹤0.01% 2719

Other funds holding ELEV

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

New York State Common Retirement Fund's ELEV Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Elevation Oncology (ELEV) in Q2 2025, closing a stake of 5,200 shares — an estimated $1.35K sold.

New York State Common Retirement Fund first reported a position in ELEV in Q2 2024 and held it in 4 quarters. The position peaked at $108K in Q2 2024. 65 funds tracked by Wall St. Rank hold ELEV as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Elevation Oncology position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 5,200 Elevation Oncology shares in Q2 2025, an estimated $1.35K.
  • New York State Common Retirement Fund first reported a position in Elevation Oncology in Q2 2024 and held it in 4 quarters.
  • New York State Common Retirement Fund's Elevation Oncology position peaked at $108K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held Elevation Oncology as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.